Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy.

Kim SM, Kim H, Yun MR, Kang HN, Pyo KH, Park HJ, Lee JM, Choi HM, Ellinghaus P, Ocker M, Paik S, Kim HR, Cho BC
Oncogenesis. 2016 Jul 18;5(7):e241. doi: 10.1038/oncsis.2016.48. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.